000 -LEADER |
fixed length control field |
03345nam a22004455i 4500 |
001 - CONTROL NUMBER |
control field |
978-1-84628-015-3 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20161121230556.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100301s2005 xxk| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781846280153 |
-- |
978-1-84628-015-3 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/b136185 |
Source of number or code |
doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC870-923.2 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC875-899.5 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJS |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED088000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.6 |
Edition number |
23 |
245 10 - TITLE STATEMENT |
Title |
Urological Cancers |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
edited by Jonathan Waxman. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
London : |
Name of producer, publisher, distributor, manufacturer |
Springer London, |
Date of production, publication, distribution, manufacture, or copyright notice |
2005. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XVI, 342 p. 45 illus., 31 illus. in color. |
Other physical details |
online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Prostate Cancer -- The Molecular Biology of Prostate Cancer -- Familial Prostate Cancer -- Screening for Prostate Cancer -- Diet and Prostate Cancer -- Radical Radiotherapy for Prostate Cancer -- Prostate Cancer: Immediate vs. Deferred Treatment -- Surgical Treatment of Prostate Cancer -- Hormone Therapy for Prostate Cancer -- Chemotherapy in Prostate Cancer -- Proteomic Approaches to Problem Solving in Prostate Cancer -- Gene Therapy for Prostate Cancer -- Bladder Cancer -- Molecular Biology of Bladder Cancer -- Treatment Options in Superficial (pTA/pT1/CIS) Bladder Cancer -- Chemotherapy for Bladder Cancer -- Gene Therapy of Urothelial Malignancy -- Kidney Cancer -- Molecular Biology of Kidney Cancer -- Cytokine and Angiogenesis Inhibitors -- Novel Therapies for Renal Cell Cancer -- Testicular Cancer -- Genetics and Biology of Adult Male Germ Cell Tumors -- Chemotherapy for Testicular Cancer -- Surgery for Testicular Cancer -- Pathobiological Basis of Treatment Strategies of Germ Cell Tumors -- Penile Cancer -- A Scientific Understanding of the Development of Penile Tumors -- The Clinical Management of Penile Cancer -- Unusual Urological Tumors -- Oncocytomas and Rare Renal Tumors -- Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations. This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Oncology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Urology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine & Public Health. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Urology. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Oncology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Waxman, Jonathan. |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Printed edition: |
International Standard Book Number |
9781852339111 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/b136185 |
912 ## - |
-- |
ZDB-2-SME |